Dow breaches 27,000; healthcare in spotlight after Trump's decision on rebate
Thursday, 11 July 2019 () U.S. stocks rose on Thursday on improved bets of an interest rate cut following Fed chief Jerome Powell's dovish remarks, while healthcare stocks were mixed after the Trump administration withdrew a rule that would kill rebates.
The government's decision to drop its plan to cut drug rebates from government drug plans could be a negative factor for pharma, according to AstraZeneca Biopharmaceuticals President Ruud Dobber. The Trump Administration announced it is no longer pursuing a proposal to eliminate drug rebates from...
The 2020 presidential election will soon become a factor in financial markets, but retirement investors are more concerned about other areas of their finances as the election approaches. Here are the..